Key Takeaways GLP-1 receptor agonists are mainly used for weight management and diabetes, but they also seem to affect the brain
However, careful attention to dosage, baseline Se status, and individual variability is essential to maximize benefits while avoiding toxicity
According to the Environmental Protection Agency (EPA), chronic inhalation of EtOat levels once considered safehas been linked to an increased risk of cancer, genetic damage, and immune system suppression
Clinical trials of semaglutide showed that gastrointestinal symptoms, including constipation, occurred in 26% of participants receiving the highest maintenance doses
It works as an appetite suppressant, helping to control cravings, support healthy portion control, and encourage weight loss
Safety monitoring is essential, including assessment for hypoglycaemia risk, diabetic ketoacidosis, gastrointestinal effects, renal function, and pancreatitis